載入...
Minnelide reduces tumor burden in preclinical models of osteosarcoma
Osteosarcoma is the most common bone cancer in children and adolescents with a five-year survival rate of about 70%. In this study, we have evaluated the preclinical therapeutic efficacy of the novel synthetic drug, Minnelide, a prodrug of triptolide on osteosarcoma. Triptolide was effective in sign...
Na minha lista:
| 發表在: | Cancer Lett |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4386634/ https://ncbi.nlm.nih.gov/pubmed/23499892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2013.02.050 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|